ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,191.90
-1.23%
S&P ASX All Technology
3,746.90
-2.57%
Brent Oil
80.725
0.14%
US Dollar vs AUD
1.62913
0.26%
Bitcoin
94,116.21
-0.39%
Pepperstone
Advertisement
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC

  6. MYND Life Sciences Inc (PK) (MYNDF) Share Price

MYND Life Sciences Inc (PK)

MYND Life Sciences Inc (PK) (MYNDF)

USOTC
0.0125
0.00
(0.00%)
Closed 13 January 8:00AM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
0.0125
Bid
0.0125
Offer
0.1215
Volume
-
0.00 Day's Range 0.00
0.0125 52 Week Range 0.0675
Market Cap
597.715k
Previous Close
0.0125
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
4,605
Shares Outstanding
47,817,182
Dividend Yield
-
PE Ratio
-0.32
Earnings Per Share (EPS)
-0.03
Revenue
-
Net Profit
-1.52M

About MYND Life Sciences Inc (PK)

Sector
Pharmaceutical Preparations
Industry
Coml Physical, Biologcl Resh
Website
www.myndsciences.com
Headquarters
Vancouver, British Columbia, Can
Founded
2020
MYND Life Sciences Inc (PK) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker MYNDF. The last closing price for MYND Life Sciences (PK) was US$0.01. Over the last year, MYND Life Sciences (PK) shares have traded in a share price range of US$ 0.0125 to US$ 0.0675.

MYND Life Sciences (PK) currently has 47,817,182 shares in issue. The market capitalisation of MYND Life Sciences (PK) is US$597,714.78 . MYND Life Sciences (PK) has a price to earnings ratio (PE ratio) of -0.32.

Ask ADVFN Intelligence (AI)

MYNDF Latest News

More News

Looking for the MS Biomarker to Revolutionize Treatment

Multiple sclerosis (MS) affects almost three million people in the world, and Canada has one of the highest rates of any country. This company is trying to find a way to identify the markers to To...

19 November 2021
AllPennyStocks.com
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1000.01250.01250.012595000.0125CS
4000.01250.01250.012595000.0125CS
12000.01250.06750.012546050.0378355CS
26000.01250.06750.012530700.0378355CS
52-0.00795-38.87530562350.020450.06750.012531750.02768262CS
156-0.16289-92.87302582820.175390.175390.012540440.0426076CS
260-0.7224-98.29908831130.73491.10.012534040.0786199CS

MYNDF - Frequently Asked Questions (FAQ)

What is the current MYND Life Sciences (PK) share price?
The current share price of MYND Life Sciences (PK) is US$ 0.0125
How many MYND Life Sciences (PK) shares are in issue?
MYND Life Sciences (PK) has 47,817,182 shares in issue
What is the market cap of MYND Life Sciences (PK)?
The market capitalisation of MYND Life Sciences (PK) is USD 597.71k
What is the 1 year trading range for MYND Life Sciences (PK) share price?
MYND Life Sciences (PK) has traded in the range of US$ 0.0125 to US$ 0.0675 during the past year
What is the PE ratio of MYND Life Sciences (PK)?
The price to earnings ratio of MYND Life Sciences (PK) is -0.32
What is the reporting currency for MYND Life Sciences (PK)?
MYND Life Sciences (PK) reports financial results in CAD
What is the latest annual profit for MYND Life Sciences (PK)?
The latest annual profit of MYND Life Sciences (PK) is CAD -1.52M
What is the registered address of MYND Life Sciences (PK)?
The registered address for MYND Life Sciences (PK) is 700 9 AVENUE, SW, #3000, VANCOUVER, BRITISH COLUMBIA, T2P 3V4
What is the MYND Life Sciences (PK) website address?
The website address for MYND Life Sciences (PK) is www.myndsciences.com
Which industry sector does MYND Life Sciences (PK) operate in?
MYND Life Sciences (PK) operates in the COML PHYSICAL, BIOLOGCL RESH sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CRGPCalissio Resources Group Inc (CE)
US$ 0.0004
(39,900.00%)
20k
SMMESmartMetric Inc (PK)
US$ 0.0001
(9,900.00%)
1.25M
NEOMNeoMedia Technologies Inc (CE)
US$ 0.0001
(9,900.00%)
534.97k
RRGIReality Racing Inc (CE)
US$ 0.0001
(9,900.00%)
209k
ELIQQElectriq Power Holdings Inc (CE)
US$ 0.0001
(9,900.00%)
290
IBKKFImining Technologies Inc (CE)
US$ 0.000001
(-100.00%)
100
EGIOQEdgio Inc (CE)
US$ 0.000001
(-99.99%)
905
CYBFCyberfort Software Inc (CE)
US$ 0.000001
(-99.88%)
20k
CHMJDWaverunner Capital Inc
 0.0045
(-99.40%)
106
CCTLCoin Citadel (PK)
US$ 0.000001
(-99.00%)
108k
HMBLHUMBL Inc (PK)
US$ 0.0009
(0.00%)
359.72M
GRLFGreen Leaf Innovations Inc (PK)
US$ 0.00015
(50.00%)
194.9M
AITXArtificial Intelligence Technology Solutions Inc (PK)
US$ 0.00375
(-1.32%)
188.36M
TSOITherapeutic Solutions International Inc (PK)
US$ 0.0002
(-33.33%)
168.26M
PHILPHI Group Inc (PK)
US$ 0.00025
(-16.67%)
129.87M

Discussion

View Full Feed
mining hound mining hound 9 minutes ago
Hi all, thanks for happy new year wishes and I wish the same for all here too!
HLLXF
gfp927z gfp927z 18 minutes ago
>>> Abbott Laboratories (NYSE: ABT) is a well-diversified healthcare company, with four distinct units: Medical devices, diagnostics, nutrition, and established pharmaceuticals. This is great because it means if one of these businesses faces tough times, another could compensate and maintain overall
ABT
gfp927z gfp927z 19 minutes ago
>>> Abbott Laboratories (NYSE: ABT) is a well-diversified healthcare company, with four distinct units: Medical devices, diagnostics, nutrition, and established pharmaceuticals. This is great because it means if one of these businesses faces tough times, another could compensate and maintain overall
ABT
georgebailey georgebailey 19 minutes ago
Steady I think the rubber hits the road when we see the MHRA label assignment on L. Based on safety, phase 3 and RWE we just might see a broad scope label which I’ll call a home run.
NWBO
Birdbrain Ideas Birdbrain Ideas 20 minutes ago
If what you suggest is a possibility, I would view the early December "Investor's Day" in hindsight as more of a dog and pony show for potential buyers. At this point, investors have been beaten to the point that most of us would accept if the company was sold for $6 or $7 a share. What would that b
AMRN
devil dog 96 devil dog 96 22 minutes ago
In October of 2023 The best setup in the OTC challenge was posted and ATMH still holds the #1 spot! Not one ticker has been found with a better setup! 🏆️

If anyone wants to take the challenge and prove me wrong here is the link https://investorshub.advfn.com/b
ATMH
3jack 3jack 22 minutes ago
We will persevere!
AVXL
gfp927z gfp927z 23 minutes ago
>>> Intuitive Surgical (NASDAQ: ISRG) is the global leader in robotic surgery. With a compound annual growth rate of about 15%, this market is expected to reach more than $25 billion by 2030, according to Meticulous Research. Intuitive's flagship product is the da Vinci, a system used in a wide vari
ISRG
3jack 3jack 23 minutes ago
We know who you are!
AVXL
gfp927z gfp927z 23 minutes ago
>>> Intuitive Surgical (NASDAQ: ISRG) is the global leader in robotic surgery. With a compound annual growth rate of about 15%, this market is expected to reach more than $25 billion by 2030, according to Meticulous Research. Intuitive's flagship product is the da Vinci, a system used in a wide vari
ISRG
Lazerator Lazerator 26 minutes ago
Not "walking dead", just dead. I just wish they'd declare bankruptcy instead of pretending like it's going to trade again.
Lazerator Lazerator 27 minutes ago
Clearly, Port turned out to be the fool. Actually, he made fools of all you guys who bought into his scam.
imho imho 27 minutes ago
In the comment section of this article,
https://seekingalpha.com/article/4748984-playing-the-odds-of-anavex-alzheimers-drug-approval#scroll_comments

Someone named Stephen Ayers in his Saturday, 12:42PM comment, says

I asked ChatGPT why the following statement, w
AVXL
Ryoko Ryoko 28 minutes ago
It's not going to be audited. They lied again. They do that once a year. Been that way for the last 4 years.
IBGR
axelvento axelvento 31 minutes ago
has announced that it will be paying its dividend of $0.43 on the 7th of March, an increased payment from last year's comparable dividend. This makes the dividend yield 6.5%, which is above the industry average

$PFE
PFE
Steady_T Steady_T 33 minutes ago
You might be correct about the size of the GBM market in the UK. However you are missing the point.

Approval in the UK validates the MOA and the potential of treating other solid cancers. That will have much more impact than the limited size of the UK market.

Approval
NWBO
skitahoe skitahoe 34 minutes ago
While I'd love you to be right, that would represent over a $14 billion market cap, I believe that's high until the EDEN is available for production of the vaccine. I just don't believe that enough vaccine can be produced in Sawston to justify that market cap until they can make more, which require
NWBO
Saving Grace Saving Grace 34 minutes ago
Putz: We are not at 2 years. Who's we? LoL SMH

Keep an eye on the door. Big revelation! It's coming. UK
NB
elks elks 35 minutes ago
Thanks.
RDAR
commdude commdude 35 minutes ago
I purchased some MJLink stocks a few years ago via their web portal. I assume they are pretty much worthless now, or????  

It wasn't a large investment, and just crossed my mind that I have them after revisiting this forum.
WDLF
TradingCharts TradingCharts 37 minutes ago
Page 2 Signed July 26, 2024

https://cases.stretto.com/public/X063/10210/PLEADINGS/1021007262480000000235.pdf
7. Stalking Horse. The Trustee has demonstrated a sound business justification for
the Court to approve (i) Meteor Energy, LLC or its designee as the Stalking
IBATF
Steady_T Steady_T 40 minutes ago
Good article with a positive slant. It did touch on the potential negatives to give some balance.

Hopefully that is enough depth to generate some interest in Anavex. He did make clear that the approval is likely to be late in the year.

At this point I see a lot of vola
AVXL
axelvento axelvento 41 minutes ago
Why Is There No Vaccine For Norovirus As It Spreads Across US? How Much Do You Need To Wait ?
Among the most promising is the vaccine candidate from Moderna—currently being tested in human participants, says Health.com

https://www.timesnownews.com/health/why-is-there-no-vaccine
MRNA
Oleblue Oleblue 41 minutes ago
D-Wave Announces 2024 Bookings and First On-Premise Advantage System Sale

Capital Markets, Quantum Computing Business

Cierra Choucair
January 10, 2025

D-Wave Quantum Inc. reported fiscal year 2024 bookings exceeding $23 million, a
QBTS

Your Recent History

USOTC
MYNDF
MYND Life Sciences (PK)
NYSE
MUR
Murphy Oil
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads